Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL28416673 | 0.98 | CYP3A4 (0.35) | CYP3A4TDP1ADH1BADH1CADH1A | |
| SCHEMBL11550852 | 0.87 | HIF1A (0.36) | CYP3A4TDP1ADH1BADH1CADH1A | |
| SCHEMBL22458131 | 0.85 | HIF1A (0.35) | CYP3A4TDP1ADH1BADH1CADH1A | |
| SCHEMBL18845437 | 0.84 | TSHR (0.35) | CYP3A4TDP1ADH1BADH1CADH1A | |
| SCHEMBL4749847 | 0.77 | CYP3A4 (0.36) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL27343 | 0.77 | CYP3A4 (0.50) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL6349486 | 0.76 | TDP1 (0.39) | CYP3A4TDP1ADH1BADH1CADH1A | |
| Phosphine SCHEMBL25423478 | 0.75 | CYP3A4 (0.47) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL9803502 | 0.75 | CYP3A4 (0.47) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL22749137 | 0.75 | CYP3A4 (0.47) | CYP3A4TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8080667-B2 | Electroluminescent metal complexes with triazoles and benzotriazoles | BASF SE (DE) | 2011-12-20 | — | — | US | claimed |
| US-7820828-B2 | Electroluminescent metal complexes with triazoles and benzotriazoles | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-10-26 | — | — | US | claimed |
| US-20100244014-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-09-30 | — | — | US | claimed |
| CN-115135698-B | Process for producing cyclic polysiloxane | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| EP-1893718-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENOTRIAZOLES | UDC IRELAND LTD (IE) | 2018-10-03 | — | — | EP | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| EP-1966343-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| CN-106165175-A | High molecular electrolyte composition and use its polyelectrolyte membrane, film electrode composite element and polymer electrolyte fuel cell | 东丽株式会社 | 2016-11-23 | — | — | CN | disclosed |
| US-9472762-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2016-10-18 | — | — | US | disclosed |
| US-20040094769-A1 | Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-05-20 | — | — | US | disclosed |
| US-20040089867-A1 | Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2004-05-13 | — | — | US | disclosed |
| US-6670645-B2 | Bright, efficient, stable; increased volatility for lower temperature vacuum deposition preventing decomposition | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-12-30 | — | — | US | disclosed |
| WO-2003063555-A1 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS WIHT FLUORINATED PHENYLPYRIDINES, PHENYLPYRIMIDINES, AND PHENYLQUINOLINES AND DEVICES MADE WITH SUCH COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20030108771-A1 | Electroluminescent platinum compounds and devices made with such compounds | E.I. DU PONT DE NEMOURS AND COMPANY | 2003-06-12 | — | — | US | disclosed |
| US-20030096138-A1 | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | LG CHEM, LTD. (KR) | 2003-05-22 | — | — | US | disclosed |
| WO-2003040256-A2 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS HAVING RED-ORANGE OR RED EMISSION AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003040257-A1 | ELECTROLUMINESCENT PLATINUM COMPOUNDS AND DEVICES MADE WITH SUCH COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| US-20020190250-A1 | Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds | LG CHEM, LTD. (KR) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | CYP3A4 152/4885TDP1 2226/4885ADH1B 121/4885 |
| US-20100244014-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES AND BENZOTRIAZOLES | OCIAD1, OXA1L, OCIAD2 | CYP3A4 243/4885TDP1 2004/4885ADH1B 330/4885 |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | NDUFS2, OCIAD2, NDUFS3 | CYP3A4 470/4885TDP1 3871/4885ADH1B 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.